P04.07 EXPRESSION PROFILE OF ANGIOGENIC FACTORS IN PAIRED INITIAL AND RECURRENT GLIOBLASTOMA

Por Tabouret, E., Tchoghandjian, A., Denicolai, E., Delfino, C., Metellus, P., Barrie, M., Boucard, C., Ouafik, L., Figarella-Branger, D., Chinot, O.
Publicado em 2014

P04.08 PLASMA LEVELS AND TUMOR TISSUE RNA OF MMP2 AND MMP9 EXHIBIT SIMILAR DISTRIBUTION IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA (GB)

Por Tabouret, E., Boudouresque, F., Denicolai, E., Barrié, M., Boucard, C., Metellus, P., Autran, D., Figarella-Branger, D., Ouafik, L., Chinot, O.
Publicado em 2014

P08.07 LEPTOMENINGEAL GLIOMATOSIS: A SINGLE INSTITUTION RETROSPECTIVE STUDY OF 31 PATIENTS

Por Autran, D., Tabouret, E., Barrié, M., Boucard, C., Terciolo, A., Loundou, A., Metellus, P., Dufour, H., Figarella-Branger, D., Chinot, O.L.
Publicado em 2014

P17.20 PATTERNS OF CARE AND OUTCOME FOR PATIENTS WITH RECURRENT GLIOBLASTOMA

Por De Cock, L., Sala, Q., Barrie, M., Boucard, C., Metellus, P., Tabouret, E., Padovani, L., Figarella-Branger, D., Dufour, H., Chinot, O.
Publicado em 2014

Inhibitor of apoptosis protein expression in glioblastomas and their in vitro and in vivo targeting by SMAC mimetic GDC-0152

Por Tchoghandjian, A, Soubéran, A, Tabouret, E, Colin, C, Denicolaï, E, Jiguet-Jiglaire, C, El-Battari, A, Villard, C, Baeza-Kallee, N, Figarella-Branger, D
Publicado no Cell Death Dis (2016)